Multiple Sclerosis

What is multiple sclerosis?

Multiple sclerosis (MS) is a disease of the central nervous system, estimated to affect 2.3 million people worldwide. It is a chronic disease in which the immune system abnormally attacks the insulation and support around the nerve cells (myelin sheath) in the brain, spinal cord and optic nerves, causing inflammation and consequent damage. MS is a leading cause of non-traumatic disability in young people, usually striking between 20 and 40 years of age. There is no cure for MS, but research continues to better understand and treat the disease.

 

What does clinical research in MS mean for me?

Clinical trials are essential to improving the lives of those living with chronic conditions like multiple sclerosis (MS). To help navigate this journey, we’ve introduced a new resource: “What does clinical research in MS mean for me?” Co-created with the Roche MS Patient Squad—a global group of patient advocates—this guide is designed for individuals living with MS, their families, and care partners. It provides a clear look into:

  • The Big Picture: Why research matters and how the study process works.
  • The Essentials: The potential benefits and considerations of participation.
  • The Experience: What to expect as a study participant.
  • The Conversation: Key questions to ask your doctor to ensure you feel confident and informed. Knowledge is power—explore the guide today to learn more.


Click to download – What does clinical research in MS mean for me?

Learn more about multiple sclerosis and research at Roche.

For patients in the US, learn more about multiple sclerosis and research at Genentech.

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Find out now